CNSP

Conviction 35HealthcareScan · Thu, Jun 25, 2026

Bullish marubozu

CNSP$4.15-0.48%

ResistanceSupportVol 14Insider buy

Vol MA14 17.26K

Mar 26Apr 14May 1May 19Jun 8Jun 25

CNS Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.cnspharma.com ↗

Price4.15

Change-0.48%

Gap-4.08%

Rel volume0.00×

Avg volume19.17K

Avg $ vol92.57K

SMA 204.75

SMA 504.54

SMA 2005.56

Price vs 50-8.52%

Price vs 200-25.41%

MA stackbearish

50/200 cross—

Supertrenddown · 5.13

RSI (14)41

MACD hist-0.11

MACD cross—

Stoch %K / %D16 / 12

ADX (14)13

+DI / −DI22 / 25

RSI divergence—

MACD divergenceBullish

ATR %+9.85%

ADR %6.54%

52w high10.57

52w low0.7451

From 52w high-60.74%

Above 52w low+456.97%

New 52w highNo

SqueezeOff

Bollinger width29.57%

%B0.07

Donchian pos13.42%

Donchian high5.44

Donchian low3.95

AVWAP (52w high)8.29

vs AVWAP high-49.95%

AVWAP (52w low)8.21

vs AVWAP low-49.48%

OBV trendFlat

Chaikin MF (20)-0.08

Today vs 20d0.00×

Avg vol (14d)17.26K

Avg vol (20d)19.17K

Avg $ vol (20d)92.57K

Market cap6.07M

RS 3m (vs SPY)+41.62%

RS 6m (vs SPY)-43.68%

RS line new highNo

Trend template2/8

Technical rank14.2

1 week-8.39%

1 month-20.50%

3 months+52.01%

6 months-36.33%

1 year+447.49%

YTD-21.70%

P/E-0.38

P/B85.78

P/S—

P/FCF-0.44

EPS-35.75

Div yield—

ROE—

ROA-340.64%

Debt/Eq6.36

Current0.89

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-6.68%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value3.56M

Revenue—

Net income-4.94M

Gross profit—

Free cash flow-13.83M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out1.46M

Employees8

ListedFri, Nov 8, 2019

Free float798.55K

Float %98.4%

Short interest48.55K

Days to cover0.4d

Short volume52.7%

Squeeze score23 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction35 / 100

Pattern quality—

Tech rank14.2 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish marubozu

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CNSP

All disclosures →

No recent disclosed trades by Congress in CNSP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CNSP · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Charles Faith L. Director · Common Stock · 2026-05-18	Buy	7.1K	$34K	2026-05-18	2026-05-20

SEC filings

EDGAR filings in CNSP

EDGAR →

No recent SEC filings on file for CNSP.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.